Omega-3 fatty acid supplementation to prevent recurrent preterm birth: a randomized controlled trial - Wikidata - wikimedia - TriplyDB

Omega-3 fatty acid supplementation to prevent recurrent preterm birth: a randomized controlled trial

Omega-3 fatty acid supplementation to prevent recurrent preterm birth: a randomized controlled trial

http://www.wikidata.org/entity/Q33618715

about

Omega-3 supplementation during pregnancy to prevent recurrent intrauterine growth restriction: systematic review and meta-analysis of randomized controlled trials Endothelial dysfunction and preeclampsia: role of oxidative stress Maternal micronutrient status and preterm versus term birth for black and white US women.Docosahexaenoic acid supplementation early in pregnancy may prevent deep placentation disorders.Evidence regarding an effect of marine n-3 fatty acids on preterm birth: a systematic review and meta-analysis.DHA supplementation and pregnancy outcomes.Do in utero events contribute to current health disparities in reproductive medicine?Omega-3 fatty acids EPA and DHA: health benefits throughout life.Fish Oil Supplementation does not Reduce Risks of Gestational Diabetes Mellitus, Pregnancy-Induced Hypertension, or Pre-Eclampsia: A Meta-Analysis of Randomized Controlled Trials Dietary Omega-3 Fatty Acid Supplementation Reduces Inflammation in Obese Pregnant Women: A Randomized Double-Blind Controlled Clinical Trial.Fish oil supplementation improves pregnancy outcomes and size of the newborn: a meta-analysis of 21 randomized controlled trials.Assessment of DHA on reducing early preterm birth: the ADORE randomized controlled trial protocol.Vitamin D status and recurrent preterm birth: a nested case-control study in high-risk women Care for women with prior preterm birth.Fish consumption, erythrocyte fatty acids, and preterm birth.Advanced lipoprotein measures and recurrent preterm birth.Increased tissue levels of omega-3 polyunsaturated fatty acids prevents pathological preterm birth.Cytokine gene polymorphisms and length of gestation Change in mononuclear leukocyte responsiveness in midpregnancy and subsequent preterm birth.Nonresponse to 17-alpha hydroxyprogesterone caproate for recurrent spontaneous preterm birth prevention: clinical prediction and generation of a risk scoring system.Omega 3 fatty acids, gestation and pregnancy outcomes.Omega-3 long-chain polyunsaturated fatty acids and fish oil supplementation during pregnancy: which evidence?Recent Progress in Therapeutics for Inflammation-Associated Preterm Birth: A Review.Risk of recurrent spontaneous preterm birth: a systematic review and meta-analysis.What we have learned about the design of randomized trials in pregnancy.Thoughts on the future of reproductive and perinatal epidemiology.Oxidized fish oil in rat pregnancy causes high newborn mortality and increases maternal insulin resistance.The Effect of Omega-3 Docosahexaenoic Acid Supplementation on Gestational Length: Randomized Trial of Supplementation Compared to Nutrition Education for Increasing n-3 Intake from Foods Characteristics of participants in peripartum interventional research.The association among cytochrome P450 3A, progesterone receptor polymorphisms, plasma 17-alpha hydroxyprogesterone caproate concentrations, and spontaneous preterm birth.Omega-3 Long-Chain Polyunsaturated Fatty Acids and Preeclampsia: Trials Say "No," but Is It the Final Word?The effect of omega-3 supplementation on pregnancy outcomes by smoking status.Maternal high-fat diet influences outcomes after neonatal hypoxic-ischemic brain injury in rodents.Personalized Medicine Enrichment Design for DHA Supplementation Clinical Trial.Pharmacokinetics of Hydroxyprogesterone Caproate and its Primary Metabolites during Pregnancy.Maternal plasma fatty acid composition and pregnancy outcome in adolescents Plasma Concentrations of Long Chain N-3 Fatty Acids in Early and Mid-Pregnancy and Risk of Early Preterm Birth

P2860

Q26864780-77C7E458-33BB-485C-8A14-4294EB60C923 Q27004643-B77880D7-664B-4B3D-88F6-429ECE4F7482 Q33714239-0D32C5BF-513C-4291-923F-D24D875E4114 Q33850028-A8A60E81-E9AC-4014-8786-085F583767A9 Q33887455-66A27A94-2FBB-4E76-8448-BEC2F245A1B1 Q34035656-47CBF85F-76C0-4A5D-8AC6-9C6502492ED4 Q34124941-689669D1-20F1-4FE7-8801-28B1D30A2C70 Q34635830-D56330EA-3318-4A01-8E74-6525D91F6594 Q35740759-82D701E0-56A1-49ED-8033-2D3A47BDAD6D Q35764644-CEAA2D50-AA4C-43CF-8649-EA2EC6D871F8 Q35969619-52B20151-6D5F-4F5A-9C6B-2F2CC3EE9B99 Q36279075-9EB5A3C0-82AD-4E4C-A6AE-1381C1E1B517 Q36537925-3BCAC9CA-4A9D-41C1-B1EA-9CC4B259784D Q36829111-F678EA47-9203-4006-9B0C-5DC9AD109FF0 Q37125630-77C58DC0-8F84-4E5F-B070-6990BB9B771B Q37205849-FCBC81A9-7214-4A52-A287-57CC8DDDD0E2 Q37272240-C27968EA-4FA9-4883-84C9-BB1653DD4869 Q37285822-681391DE-91AB-4E88-BCD8-0CF1A7BDFB01 Q37315255-2CB0B924-E4B1-478E-9970-F61B74BA92BE Q37835466-EE1AC74D-E324-4C2C-9887-081A3551DB38 Q38010564-E8754347-0D18-4E51-B7F5-8034A3FA4C36 Q38588701-FCFE60BA-FE7E-4215-B520-0BB3C9A9C3BD Q38655581-69BC06ED-4185-44D2-92D9-5B64CDB5212F Q38692358-513A6973-F91B-468E-B2EC-2E425DD140B4 Q38877043-E367D210-554E-42AE-9492-89CD7F17B29D Q39507939-4F39576B-5ABE-4D87-8601-43FDB806BE6A Q39625842-B9898F80-C86C-4447-AF4D-0B8085C6F1F5 Q40492670-EE0AF9DA-10F1-43BA-8E3E-09A1DD996B32 Q41034840-88F01032-1FC7-4AC3-A6E5-C859D6051150 Q46304188-834B6281-15DB-4268-9A23-702CE132E59A Q47779776-F6FC365E-258F-43D5-8660-E86CED5ED941 Q47801976-14ECF464-8D87-418A-B114-54BD55974348 Q49034754-6B8D7C17-3819-42F0-8C4D-4EE4B435F5E7 Q53784044-B4C32430-6E77-4A77-AEFF-C7E0089A5E12 Q55040122-56E4D248-244E-4691-BE40-EA5CDCAEA9FC Q57624239-FCBCF99E-4F07-4E0D-802D-A2B7E31B2351 Q58800819-874DCD17-5634-423B-8D6D-0677480511D5

P2860

Omega-3 fatty acid supplementation to prevent recurrent preterm birth: a randomized controlled trial

http://www.wikidata.org/entity/Q33618715

description

2010 nî lūn-bûn

@nan

2010 թուականի Փետրուարին հրատարակուած գիտական յօդուած

@hyw

2010 թվականի փետրվարին հրատարակված գիտական հոդված

@hy

2010年の論文

@ja

2010年論文

@yue

2010年論文

@zh-hant

2010年論文

@zh-hk

2010年論文

@zh-mo

2010年論文

@zh-tw

2010年论文

@wuu

name

Omega-3 fatty acid supplementa ...... a randomized controlled trial

@ast

Omega-3 fatty acid supplementa ...... a randomized controlled trial

@en

type

label

Omega-3 fatty acid supplementa ...... a randomized controlled trial

@ast

Omega-3 fatty acid supplementa ...... a randomized controlled trial

@en

prefLabel

Omega-3 fatty acid supplementa ...... a randomized controlled trial

@ast

Omega-3 fatty acid supplementa ...... a randomized controlled trial

@en

P1433

Q33618715-5D91E2E4-EFDB-4A38-AE1B-2389D131A752

P1476

Q33618715-4AAD0922-886A-4224-A6E3-4A2A93F31AE7

P2093

Q33618715-162FAB7C-9709-45BC-816C-FFA9E3733C0A

Q33618715-202088BF-DDE1-45F7-A596-16E7D2417239

Q33618715-3020C418-D680-488D-8188-16C8DB7E7E93

Q33618715-5361F0AA-1E79-4041-830C-BD55D3C1AD3D

Q33618715-736A1AC5-CD27-4802-A743-247A9A31D4EE

Q33618715-8344FB96-9AE8-4F19-8C58-F3E8BE55946E

Q33618715-8EB668E8-865E-42C7-ACFE-15CA0BB1D614

Q33618715-A2FD9626-4BE7-4612-AE4E-D138EF2FDD37

Q33618715-BB653FB5-F0E6-464C-973D-F155E6CC269D

Q33618715-FAAAE586-F785-4172-9DFB-A99E6E8A9D1D

P2860

Q33618715-01A28ADE-7BCB-476D-B221-FEC2C38A726E

Q33618715-088C8033-CA0B-4F26-8F4E-F42DAE657E6E

Q33618715-20DFF0D9-3DB9-47CF-B65C-5B44870D3024

Q33618715-2247B372-B2EC-46ED-928B-D52D27E41CAD

Q33618715-25765975-FC0E-43DB-A6B1-7985DBC97CF5

Q33618715-2B55EA8C-32E2-4E59-B77E-087E1E926150

Q33618715-457CC747-5C62-467D-995D-B88E05430652

Q33618715-4E97AFEF-EE2B-4EA5-AE0C-CD2C866BB2D3

Q33618715-5E580138-40A3-4619-AB8D-91A13F41EA7E

Q33618715-63AA88F4-80E7-4285-A73E-5E28469009C9

P304

Q33618715-A8F4A251-2AE1-4B57-8570-4A34A44581FD

P31

Q33618715-C1CEF130-DC94-4C66-B0CB-569EC39AE56C

P356

Q33618715-3FB7DD1A-4988-41DF-98B2-E6B5F8EADC60

P407

Q33618715-D804500B-4B12-46BC-B1CD-2C1D5A2242F5

P433

Q33618715-43507360-AD8C-4048-AE8D-325B98D24154

P478

Q33618715-82CF69B3-0F53-4C65-B9C9-109B80D0DE6F

P50

Q33618715-64F06982-242B-4A51-B1E9-A8E3DC83423E

Q33618715-67409ABF-7397-478B-B52F-397CD4CA35CA

Q33618715-7C2383E2-AA52-44D6-97FC-027BE806335E

Q33618715-9EF9693D-E3BB-4B52-ABD6-E4141CBECCC5

Q33618715-D02EAA64-C60B-4B37-9E58-FFC8C702BF20

Q33618715-FDE86C8C-6DF2-4D0A-889C-6F8FD131DD98

P577

Q33618715-CEC0898E-3D1A-4ADA-854F-E04050D2AED5

P698

Q33618715-DFC28BA6-6F7D-4853-9E25-549719DFC8E2

P921

Q33618715-B44B69A1-BAF3-4758-9DBE-EB5A2C813D30

P932

Q33618715-E733B35D-8BEE-43FE-9C9B-53C82F7F6AAA

P356

AOG.0B013E3181CBD60E

P1433

Obstetrics and Gynecology

P1476

Omega-3 fatty acid supplementa ...... a randomized controlled trial

@en

P2093

Anthony Sciscione

http://www.w3.org/2001/XMLSchema#string

Brian M Mercer

http://www.w3.org/2001/XMLSchema#string

Elizabeth Thom

http://www.w3.org/2001/XMLSchema#string

Garland D Anderson

http://www.w3.org/2001/XMLSchema#string

Jay D Iams

http://www.w3.org/2001/XMLSchema#string

John Thorp

http://www.w3.org/2001/XMLSchema#string

Margaret Harper

http://www.w3.org/2001/XMLSchema#string

Mark A Klebanoff

http://www.w3.org/2001/XMLSchema#string

Marshall W Carpenter

http://www.w3.org/2001/XMLSchema#string

Ronald J Wapner

http://www.w3.org/2001/XMLSchema#string

P2860

Marine oil, and other prostaglandin precursor, supplementation for pregnancy uncomplicated by pre-eclampsia or intrauterine growth restriction

Prevention of recurrent preterm delivery by 17 alpha-hydroxyprogesterone caproate

Reproducibility and validity of a semiquantitative food frequency questionnaire

Births: final data for 2005.

Effect of n-3 long-chain polyunsaturated fatty acid supplementation of women with low-risk pregnancies on pregnancy outcomes and growth measures at birth: a meta-analysis of randomized controlled trials.

Effect of supplementation of women in high-risk pregnancies with long-chain polyunsaturated fatty acids on pregnancy outcomes and growth measures at birth: a meta-analysis of randomized controlled trials.

The control of labor.

Polyunsaturated fatty acids in the food chain in the United States.

Randomised clinical trials of fish oil supplementation in high risk pregnancies. Fish Oil Trials In Pregnancy (FOTIP) Team.

The role of n-3 fatty acids in gestation and parturition.

P304

234-242

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1097/AOG.0B013E3181CBD60E

http://www.w3.org/2001/XMLSchema#string

P407

P433

2 Pt 1

http://www.w3.org/2001/XMLSchema#string

P478

115

http://www.w3.org/2001/XMLSchema#string

P50

Alan M. Peaceman

Michael W. Varner

Steve N Caritis

Eunice Kennedy Shriver National Institute of Child Health and Human Development Maternal-Fetal Medicine Units Network

P577

2010-02-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

20093894

http://www.w3.org/2001/XMLSchema#string

P921

P932

4022705

http://www.w3.org/2001/XMLSchema#string